Anixa Biosciences Commences Treatment of Fifth Patient in Ovarian Cancer CAR-T Clinical Trial

/PRNewswire/ -- Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a clinical-stage biotechnology company focused on the treatment and...

Related Keywords

Anixa Biosciences ,Amit Kumar ,Joser Conejo Garcia ,Mike Catelani ,Facebook ,Anixa Biosciences Inc ,Wistar Institute ,Department Of Integrative Immunobiology ,Youtube ,Linkedin ,Duke University School Of Medicine ,Moffitt Cancer Center ,Moffitt Cancer ,Integrative Immunobiology ,Duke University School ,Follicle Stimulating Hormone Receptor Mediated ,Cleveland Clinic ,Looking Statements ,Private Securities Litigation Reform Act ,Annual Report ,Quarterly Reports ,Current Reports ,